sun-pharma

Indian Pharma Market 2026: Branded Generics, GLP-1 Agonists, And Chronic Therapies Set To Drive Growth

Indian Pharma Market 2026: Branded Generics, GLP-1 Agonists, And Chronic Therapies Set To Drive Growth

The Indian Pharmaceutical Market ended 2025 with Rs 2,40,672 crore, 8.1% growth. 2026 expected to grow 7.8–8.1%, driven by pricing,…

January 8, 2026

Jefferies adds nine major players in buy list of India Equity strategy, including Reliance

New Delhi [India], September 11 (ANI): Jefferies, in its India Equity Strategy buy list, has made fresh inclusion of nine…

September 12, 2025